What is *Stem Cells: A Very Short Introduction* about?

*Stem Cells: A Very Short Introduction* provides a concise overview of stem cell biology, explaining their types (embryonic vs. tissue-specific), current applications like bone marrow transplants, and future therapeutic potential for diseases such as diabetes and Parkinson’s. Jonathan Slack clarifies misconceptions, distinguishes proven treatments from unproven therapies, and analyzes ethical debates.

Who should read *Stem Cells: A Very Short Introduction*?

This book is ideal for students, researchers, or general readers seeking a scientifically accurate yet accessible primer on stem cells. Slack’s clear explanations of complex concepts (e.g., reprogramming cells) make it valuable for anyone exploring regenerative medicine, biotechnology, or bioethics.

Is *Stem Cells: A Very Short Introduction* worth reading?

Yes—it demystifies stem cell science with balanced insights into real-world therapies (e.g., treating burns) versus aspirational claims. Slack’s expertise as a developmental biologist and his critique of unregulated clinics add authority, while the glossary aids non-experts.

What are the main differences between embryonic and tissue-specific stem cells?

Embryonic stem cells exist only in lab cultures and can differentiate into any cell type, while tissue-specific stem cells (e.g., in bone marrow) naturally renew specific tissues. Slack emphasizes that most clinical applications today involve tissue-specific cells, not embryonic ones.

How does Jonathan Slack address ethical concerns in stem cell research?

Slack acknowledges controversies around embryonic stem cells but stresses their limited current use. He critiques clinics offering unproven therapies, advocating for rigorous science over sensationalism. His analysis ties ethical debates to broader lessons about medical innovation.

What current stem cell therapies are proven effective?

Bone marrow transplantation for blood disorders is the most established therapy. Slack also highlights stem cell treatments for severe burns and corneal repair, contrasting these with speculative applications like spinal cord injury reversal.

What key concepts are explained in the book’s glossary?

Critical terms include *reprogramming* (converting cells to stem-like states), *pluripotency* (ability to become multiple cell types), and *in vitro* vs. *in vivo* applications. Slack uses these concepts to clarify misunderstandings about stem cell capabilities.

How does Slack differentiate real vs. fake stem cell treatments?

Legitimate therapies undergo rigorous trials (e.g., bone marrow transplants), while “fake” treatments lack scientific validation. Slack warns against clinics offering unproven cures for conditions like autism or aging, emphasizing regulatory gaps.

『幹細胞の基礎知識』の要約

ごく短い導入部

ジョナサン・スラック

3.85(208 Reviews)

『幹細胞の基礎知識』の要約の概要

数百万人の命を救う可能性のある科学を解明するジョナサン・スラックの著書『Stem Cells（幹細胞）』は、革命的な医療に関する誤った情報を一掃します。民間クリニックが偽りの約束を売り込む一方で、この発生生物学者は、パーキンソン病、糖尿病、脊髄損傷を実際に治療できる可能性のある療法はどれか、そしてどれが依然としてサイエンス・フィクションの域を出ないのかを明らかにします。

語り方を選ぶ

『幹細胞の基礎知識』の要約をさまざまな学習スタイルで探る

幹細胞の基礎知識の同じアイデアを、あなたに合う声・深さ・ペースで学べます。いつでも切り替えられます。

第1章

The Cellular Fountain of Youth: Unlocking the Power of Stem Cells

In a world where aging celebrities pay $25,000 for "stem cell facials" and desperate patients travel globally for unproven treatments, Jonathan Slack's exploration of stem cell science cuts through the hype with refreshing clarity. As Oprah Winfrey once highlighted on her influential show, stem cells represent "the future of medicine" - yet this future remains tantalizingly just beyond our grasp. Slack's work arrives at a critical moment when stem cell research occupies the intersection of groundbreaking science, ethical debate, and popular imagination. From Barack Obama's reversal of Bush-era research restrictions to Silicon Valley billionaires investing millions in regenerative medicine startups, stem cells have transcended pure science to become a cultural phenomenon. This comprehensive exploration takes us from the laboratory to the clinic, revealing both the extraordinary promise and sobering reality of what many consider the most important biological discovery since DNA.

第2章

The Fundamental Nature of Stem Cells: Building Blocks of Life

At their core, stem cells possess two defining characteristics that make them unique among the body's 210 different cell types: they can reproduce themselves indefinitely (self-renewal) and generate offspring that differentiate into specialized cells (potency). This remarkable dual capacity allows them to serve as both a reservoir of new cells and a factory for specialized tissue components. These properties are carefully regulated through complex molecular pathways, including key genes like Oct4, Sox2, and Nanog, which maintain the stem cell state. To understand how stem cells function in the body, consider your skin - a tissue that completely replaces itself every few weeks. Deep in the basal layer of your epidermis reside epidermal stem cells that divide asymmetrically, producing one daughter cell that remains a stem cell and another that begins a journey of transformation. This second cell, now committed to differentiation, moves upward through the epidermis, producing keratin proteins that give skin its protective properties before eventually dying and being shed from the surface. This process occurs continuously, with approximately 30,000-40,000 cells being shed every hour, demonstrating the remarkable regenerative capacity of stem cells. What makes stem cells truly special is their microenvironment or "niche" - a specialized local ecosystem that supports their function. In skin, stem cells associate with dermal papillae; in intestines, they nestle alongside Paneth cells in crypts; in bone marrow, they reside near blood vessels. These niches provide crucial signals that maintain stemness and prevent inappropriate differentiation. The niche includes both cellular and non-cellular components, such as growth factors, extracellular matrix proteins, and mechanical forces. For example, in bone marrow, osteoblasts secrete factors like CXCL12 that help retain hematopoietic stem cells in their niche. The study of stem cells relies heavily on tissue culture - growing cells outside the body in artificial media. This technique, pioneered in the late nineteenth century and refined by Alexis Carrel, became widespread in the 1950s with the development of commercial media and antibiotics. When tissue fragments are placed in culture, only certain cells migrate out and grow, typically forming a monolayer on plastic surfaces. Once confluent, these cells are subcultured using enzymes like trypsin to detach them for continued growth in fresh containers. Modern stem cell culture has evolved to include specialized techniques like suspension culture for embryonic stem cells and 3D organoid systems that better mimic natural tissue architecture. However, tissue culture comes with two critical limitations. First, it accelerates cellular evolution through selection of advantageous mutations, potentially creating cells quite different from their original state. For instance, cells may acquire chromosomal abnormalities or altered growth properties after prolonged culture. Second, the artificial environment profoundly alters gene expression, meaning cultured cells often behave differently than their counterparts in living tissue. Studies have shown that up to 30% of genes may show altered expression patterns in cultured cells. These limitations become particularly important when considering therapeutic applications, as they can affect both safety and efficacy of stem cell-based treatments. Recent advances in biomaterials and tissue engineering are helping address these challenges by creating more physiologically relevant culture environments.

聴きながら、すべての言葉を目で追えます

『幹細胞の基礎知識』の要約の一語一語が音声に合わせてリアルタイムでハイライトされ、自然に読み進められます。

第3章

Embryonic Stem Cells: Potent but Controversial

Embryonic stem (ES) cells represent one of the most powerful yet controversial tools in modern biology. Derived from the inner cell mass of early embryos called blastocysts, these cells possess the remarkable ability to differentiate into virtually any cell type in the body - a property known as pluripotency. Mouse ES cells were first isolated in 1981 by Martin Evans, Matthew Kaufman, and independently by Gail Martin. These cells can grow indefinitely in culture while maintaining their pluripotency, making them invaluable research tools. When injected into mouse embryos, they integrate seamlessly and contribute to all tissues of the developing animal, including the germline. This property has revolutionized genetic research by enabling the creation of "knockout mice" - animals with specific genes disabled to study their function. In appropriate culture conditions, mouse ES cells form embryoid bodies resembling early embryos but lacking proper spatial organization. When implanted into compatible adult mice, they form teratomas - tumors containing chaotic arrangements of various tissue types, from hair to teeth to neural tissue. This teratoma-forming ability serves as the definitive test of pluripotency. Human ES cells, first isolated in 1998 by James Thomson after extensive work with non-human primates, share these fundamental properties but come with profound ethical considerations. The controversy stems solely from their embryonic origin - they require the destruction of human blastocysts, which some consider equivalent to destroying human life. These cells typically come from surplus embryos from IVF clinics, where parents may choose to donate unused embryos for research rather than discard them. The ethical debate hinges on when personhood begins. Most biomedical scientists consider personhood to develop gradually and view preimplantation embryos as more akin to cultured cells than human beings. Religious perspectives vary widely - Catholic and Buddhist views consider personhood beginning at conception, while Jewish and Islamic teachings hold embryos have no special status until 40 days, and Hindu beliefs vary based on reincarnation timing. Beyond potential therapeutic applications, human ES cells offer three other valuable uses: studying normal human development without experimenting directly on embryos; investigating cellular pathology in genetic diseases; and generating unlimited supplies of difficult-to-obtain cell types like cardiomyocytes and hepatocytes for drug screening, potentially reducing animal testing.

第4章

Personalized Pluripotent Stem Cells: The Revolution of Reprogramming

The intersection of stem cell biology with cloning technology has created one of the most remarkable breakthroughs in modern medicine: personalized pluripotent stem cells genetically matched to specific patients, potentially eliminating immune rejection concerns that plague conventional transplantation. Cloning has deep roots in developmental biology. In the early 20th century, Hans Spemann demonstrated that nuclei from early embryonic cells could support development of complete embryos. Later experiments by Briggs, King, and Gurdon showed that even nuclei from differentiated cells could, with very low efficiency, support development. The watershed moment came in 1997 when Ian Wilmut created Dolly the sheep using somatic cell nuclear transfer (SCNT) - taking a nucleus from an adult sheep cell and transplanting it into an enucleated oocyte. This technique opened the possibility of "therapeutic cloning" - creating ES cell lines genetically identical to a specific donor, not to create cloned individuals but to provide immunologically compatible cells for transplantation. However, human therapeutic cloning faces significant challenges: the process is inefficient, and obtaining human oocytes is difficult and involves risk to female volunteers. A revolutionary alternative emerged in 2006 when Shinya Yamanaka discovered induced pluripotent stem (iPS) cells. By introducing just four specific genes - Oct4, Sox2, Klf4, and c-Myc - into normal fibroblasts, he could generate ES-like cells. This discovery earned Yamanaka the Nobel Prize and sparked worldwide research activity, with human iPS cells reported just one year later. The true breakthrough of iPS technology lies in creating patient-specific stem cell lines - something that therapeutic cloning attempted but rarely achieved. Many such lines have already been established, including from people with specific genetic diseases. The key advantage is immunological compatibility - differentiated cells made from these lines would be perfect matches for their donors, potentially eliminating rejection issues. Initially made from skin fibroblasts requiring surgical biopsies, iPS cells can now be generated from simple blood samples. For clinical applications, researchers are developing methods to reprogram cells without viral DNA integration, which can cause mutations or tumor formation. Despite enthusiasm from opponents of embryonic stem cell research, iPS cells raise their own ethical questions about donor rights, genetic privacy, and potential misuse in reproductive technologies.

『幹細胞の基礎知識』の要約をもっと深く楽しむ

毎日の新しい気づきを10万件以上のレッスンから
言葉をハイライトして音声と同期
ライブラリを保存して、どの端末からでも利用

第5章

Diabetes: The Prime Target for Stem Cell Therapy

Diabetes represents perhaps the most promising target for stem cell therapy, affecting over 200 million people worldwide with numbers expected to double within 25 years. The disease's global impact is particularly severe in developing nations, where access to insulin and monitoring devices remains limited. Despite insulin's discovery in 1921 revolutionizing treatment, diabetes remains a serious condition consuming 10-15% of healthcare budgets in wealthy nations, with annual costs exceeding $760 billion globally. The long-term complications from imprecise glucose control include heart disease, stroke, blindness, kidney failure, and peripheral vascular disease, often leading to amputations and decreased quality of life. The key therapeutic target is the beta cell found in pancreatic islets of Langerhans, which produces insulin to regulate blood glucose. These specialized endocrine cells comprise just 2% of the pancreas but are crucial for enabling glucose uptake by tissues. Without insulin, blood glucose rises uncontrollably while the body cannot utilize this essential energy source. Beta cells function as sophisticated glucose sensors, releasing precise amounts of insulin in response to minute changes in blood sugar levels - a complexity that has proven challenging to replicate artificially. A partially effective cell therapy already exists: transplanting islets from deceased organ donors into diabetic patients using the Edmonton Protocol for immunosuppression. This treatment particularly helps patients with hypoglycemia unawareness - a dangerous condition where patients can't detect dangerously low blood sugar levels, risking seizures or coma. While demonstrably effective through measurable improvements in blood glucose and C-peptide levels, this approach faces two critical limitations: severely inadequate donor supply (less than 1% of need) and the need for lifelong immunosuppression, which carries risks of infection and cancer. Creating beta cells from pluripotent stem cells follows developmental biology principles established over the past 15 years. The five-step differentiation process mimics natural development: endoderm formation (using Activin A), foregut specification (through FGF and BMP inhibition), pancreatic bud development (via retinoic acid), endocrine precursor formation (through Notch inhibition), and finally beta cell maturation (using specific growth factors). Each step requires specific inducing factors, with success monitored by tracking key developmental genes such as PDX1, NGN3, and INSULIN. Current protocols produce cells resembling immature fetal beta cells that aren't fully glucose-responsive, though implanting pancreatic bud-stage cells into animals allows them to mature properly over 3-4 months. The approach would likely involve encapsulating these cells in semi-permeable materials like alginate or other biocompatible polymers to prevent immune rejection when implanted in humans while allowing insulin secretion and glucose sensing. Despite promising animal studies showing that beta cell precursors derived from human ES cells can reverse diabetes in immunodeficient mice, maintaining normal blood glucose levels for over six months, progress toward clinical application remains slow. Current diabetes treatments already offer near-normal lifespans for patients with good glucose control, setting a high bar for new therapies. Any stem cell treatment must demonstrate both superior efficacy and exceptional safety, with particular attention to preventing tumor formation and ensuring long-term cell survival. Early-phase clinical trials are now underway testing encapsulated stem cell-derived beta cells, representing a crucial step toward this revolutionary therapy.

第6章

Beyond Diabetes: The Wider Therapeutic Landscape

While diabetes represents the most promising application for stem cell therapy, researchers are pursuing several other significant targets, each with unique challenges and potential. Parkinson's disease affects 1-2% of people during their lifetime, making it the second most common neurodegenerative condition after Alzheimer's. The disease stems from the loss of dopamine-producing neurons in the substantia nigra region of the brainstem. By the time symptoms appear, patients have lost 80% or more of these cells, resulting in decreased stimulation of the motor cortex and the characteristic rigidity, tremor, and slow movements. While L-DOPA treatment has been used since the 1960s with some benefit, it causes side effects including uncontrolled movements and becomes less effective as the disease progresses. Deep brain stimulation (FDA-approved in 2002) provides another treatment option. Despite promising cell production technology and animal experiments for dopaminergic neurons from human pluripotent stem cells, the risk-benefit ratio compared to existing treatments remains unconvincing, especially considering Parkinson's patients often survive 20 years post-diagnosis, creating a long window for potential complications. Heart disease presents another major target. Unlike diabetes or Parkinson's treatments that replace specific lost cells, current clinical heart "cell therapy" doesn't actually replace cardiac muscle. Instead, researchers are developing methods to create cardiomyocytes from pluripotent stem cells, testing them in animal models where coronary arteries are ligated to simulate heart attacks. While experiments show cell persistence and improved cardiac function, results are complicated because grafts typically contain blood vessel progenitors alongside cardiomyocytes. Surprisingly, the first FDA-approved clinical trial using human ES cells targeted spinal trauma rather than these more anticipated conditions. Spinal injuries present complex challenges: damage to nerve fiber tracts causes paralysis and sensation loss, while local cell death and scar formation prevent regrowth. The Geron Corporation trial, approved in 2009 but temporarily suspended over tumor concerns, focused on introducing healthy oligodendrocytes (myelin-producing cells) to remyelinate spared fibers. Age-related macular degeneration (ARMD) represents another promising application. Affecting about 10% of people over 65, it causes deterioration of the macula - the central retinal area responsible for detailed vision. The first clinical trials using retinal pigment epithelium (RPE) cells derived from human pluripotent stem cells began in 2011. This application is particularly suitable for cell therapy given the lack of alternative treatments for the "dry" form of ARMD, the ability to monitor grafts through the pupil, and the option to remove the eye if complications arise.

聴きながら、すべての言葉を目で追えます

『幹細胞の基礎知識』の要約の一語一語が音声に合わせてリアルタイムでハイライトされ、自然に読み進められます。

第7章

The Hidden World of Tissue-Specific Stem Cells

While pluripotent stem cells capture headlines, tissue-specific stem cells quietly maintain and repair our bodies throughout life. Unlike their pluripotent counterparts, these cells are restricted in what they can become but are essential for tissue renewal and repair. Understanding tissue-specific stem cells requires examining how the body grows and renews itself. Cell turnover - involving the birth of new cells and death of old ones - varies significantly between tissues. Charles Leblond classified tissues into three types: post-mitotic (never divide after formation, like neurons), expanding (divide during growth then stop), and renewal tissues (continuously replace cells through stem cell activity). The hematopoietic system in bone marrow represents the paradigm of stem cell function. Hematopoietic stem cells (HSCs) represent only a small fraction of bone marrow cells but produce all blood and immune cells over time. Located near bone cells or blood vessels, HSCs divide to produce both self-renewal and transit amplifying cells called common lymphocyte progenitors and common myeloid progenitors, which generate all blood and immune cell types. Only renewal tissues contain true stem cells that continuously self-renew and generate differentiated cells throughout life. However, some non-renewal tissues have special regenerative populations. Skeletal muscle contains satellite cells that normally remain quiescent but activate after injury to proliferate and form new muscle fibers. The liver regenerates effectively not through stem cells but through division of existing hepatocytes, though "oval cells" in bile ducts may become either hepatocytes or bile duct cells when regular hepatocyte division is suppressed. Both neurons in the brain and cardiomyocytes in the heart are post-mitotic cells that don't normally divide once formed. In the brain, however, new neuron formation occurs in two specific regions: the lateral ventricle lining (where neurons migrate to the olfactory bulb) and the dentate gyrus of the hippocampus (involved in learning and memory). Both areas contain neural stem cells that can generate both neurons and supporting glial cells. The Karolinska Institute developed a sensitive method using carbon-14 (14C) from atmospheric nuclear tests to determine cell "birthdays." Their studies on cerebral cortex neurons showed no renewal whatsoever - all were formed during fetal life. For heart cells, turnover appears less than 1% per year, declining with age. Unlike lower vertebrates like fish and amphibians, mammals show no convincing evidence of significant cell renewal in the cerebral cortex, either normally or following damage.

第8章

Proven Therapies: Where Stem Cells Already Save Lives

While much stem cell research remains experimental, several therapies have already proven their clinical value, with hematopoietic stem cell transplantation (HSCT) standing as the gold standard. Modern HSCT has evolved significantly from its origins. For leukemia treatment, the graft's primary purpose now is to destroy residual tumor cells through the "graft-versus-leukemia" effect rather than simply rescuing patients from radiation or chemotherapy. In practice, HLA matching is scored out of 8, covering two main gene groups inherited from each parent. Siblings have a one-in-four chance of being perfect matches, but only about 20% of patients have perfectly matched siblings. Scientific advances in the 1980s led to the discovery of haematopoietic growth factors. G-CSF allows mobilization of stem cells from bone marrow into peripheral blood, enabling collection without painful bone marrow harvesting. Umbilical cord blood has become another valuable source of HSCs, containing higher concentrations than adult blood and causing less severe graft-versus-host disease. Because allogeneic HSCT remains extremely hazardous (at least 10% treatment-associated mortality), it's reserved for life-threatening conditions. Autologous transplants (using the patient's own cells) represent just over half of all HSCTs. These eliminate rejection risk but may reintroduce cancer cells. HSCT is also used for lethal genetic blood or immune system diseases and certain enzyme deficiencies. Beyond HSCT, a few other genuine stem cell therapies have proven successful. A pioneering application involves using cultured epidermis to treat severe burns. When burns are too extensive for traditional autologous skin grafts, Howard Green's method allows expansion of epidermal stem cells in culture. A small biopsy can be expanded to cover the entire body in about three weeks. Though life-saving, this therapy never became widespread due to the rarity of severe burns in wealthy countries and the absence of advanced clinical facilities in developing regions where such burns are more common. Another successful stem cell therapy addresses corneal blindness. The cornea's outer epithelial layer normally regenerates from stem cells in the surrounding limbus. When the limbus is damaged (e.g., by chemical burns), corneal transplants fail. Dr. Michele de Luca developed a method where limbal cells from a patient's healthy eye are expanded in culture and grafted to the damaged eye, restoring vision to several dozen patients. Currently no true stem cell therapy exists for the heart - no one has successfully grafted cells that repopulate and replace damaged cardiac muscle. However, numerous clinical trials have involved grafting various cell types into diseased hearts, with results showing only slight, temporary improvements in cardiac function (typically 2% increase in cardiac output lasting months).

『幹細胞の基礎知識』の要約をもっと深く楽しむ

毎日の新しい気づきを10万件以上のレッスンから
言葉をハイライトして音声と同期
ライブラリを保存して、どの端末からでも利用

第9章

Bridging Hope and Reality: The Future of Stem Cell Medicine

Despite modern medicine's achievements, we still face devastating conditions like permanent paralysis from spinal injury, limb loss, heart failure, and many cancers. While biomedical scientists believe regenerative treatments and cures will eventually emerge, progress will likely be slower than most expect. Inflated expectations stem from multiple sources: financial incentives to attract attention, ethical debates over ES cells prompting promises of rapid cures, and politicians viewing stem cell therapy as the "next big thing" to rescue failing economies. The California Institute for Regenerative Medicine exemplifies this hype, funded by $3 billion in state bonds partly to circumvent federal funding restrictions on human ES cell research. While Californians expected quick cures, scientists privately acknowledge that pluripotent stem cell therapies may take decades to materialize. Have you ever wondered why medical advances seem to come more slowly now despite vastly increased research funding? The biomedical sciences generally produce fewer clinical outputs now than in the 1940s-50s despite vastly increased investment, as the "easy" discoveries have been made and regulatory approval processes have become increasingly cumbersome. HSCT offers surprising lessons for modern stem cell therapy development. It's not a product but a service, generating wealth indirectly through ancillary products and services. The HSCT story defies prediction - it succeeded without detailed mechanistic understanding, developed without modern regulatory oversight, and its economic benefits emerged in unexpected ways. Today's regulatory environment would likely never approve such aggressive initial treatments. The positive lessons include recognizing that successful therapies require time - about 20 years passed between discovering bone marrow cells cured radiation sickness in mice and establishing human treatments. Scientific knowledge remains crucial, not necessarily for inventing treatments but for measuring outcomes accurately. Within the next few years, we'll likely see clinical trials using pluripotent cell-derived beta cells for diabetes, cardiomyocytes for heart disease, and dopaminergic neurons for Parkinson's. For tissue-specific stem cells, HSCT will see incremental improvements and expanded use for genetic diseases. "Direct reprogramming" shows particular promise - using transcription factors to transform fibroblasts or white blood cells directly into neurons, cardiomyocytes or beta cells without passing through pluripotent stages, eliminating teratoma risks. Cell reimplantation methods will also advance, moving from simple injections to sophisticated tissue-engineered implants with multiple cell types arranged in three-dimensional structures with vascular systems. Long-term, stem cell biology represents enormous potential within the broader context of regenerative medicine. However, accurate prediction remains extraordinarily difficult, making skepticism about miracle cure claims from private clinics essential. The future of stem cell medicine will likely unfold gradually through careful science rather than revolutionary breakthroughs, ultimately transforming medicine in ways we can barely imagine today.

★★★★★

『幹細胞の基礎知識』の要約を最後まで読み終えました

“23日間、毎日使い続けています。今では日課の一部です。”

jayallen

『幹細胞の基礎知識』の要約の主要テーマ

regenerative medicine
cellular differentiation
pluripotency and potency
tissue engineering
stem cell niche

『幹細胞の基礎知識』の要約の名言集

Stem cells represent 'the future of medicine' - yet this future remains tantalizingly just beyond our grasp.
The controversy stems solely from their embryonic origin.
The ethical debate hinges on when personhood begins.

『幹細胞の基礎知識』の要約の登場人物

Jonathan SlackAuthor and expert on stem cell science
Alexis CarrelPioneer of tissue culture techniques
Martin EvansScientist who first isolated mouse ES cells
Matthew KaufmanCo-discoverer of mouse embryonic stem cells
Gail MartinIndependent isolator of mouse ES cells

著者について

ジョナサン・スラック（Jonathan Slack）は、『Stem Cells: A Very Short Introduction（幹細胞：ごく短い導入）』の著者であり、再生医療と細胞リプログラミングの研究で名高い、第一線の発生生物学者です。ミネソタ大学幹細胞研究所の所長（2006年〜2012年）を歴任し、現在はバース大学の名誉教授を務めるスラックは、胚発生、組織再生、および糖尿病に関連するβ細胞工学における数十年の研究と、複雑な科学を分かりやすい物語へと凝縮する才能を兼ね備えています。

オックスフォード大学出版局の高く評価されている「Very Short Introductions」シリーズの一冊である彼の著書は、胚性幹細胞や組織特異的幹細胞、その治療の可能性、そして倫理的課題を掘り下げており、研究室での研究と臨床応用を橋渡しするという彼のキャリアを通じた一貫した姿勢を反映しています。

スラックの権威は、『Essential Developmental Biology』のような基礎的な教科書や、科学コミュニケーションにおける功績を称える英国発生生物学会の2023年ウォルパート・メダル（Wolpert Medal）の受賞などによって裏付けられています。四肢の再生や、肝細胞からインスリン産生β細胞への分換換（トランスディファレンシエーション）に関する彼の先駆的な研究は、本書における最先端治療への洞察の礎となっています。

立証されていない幹細胞治療を批判することでも知られるスラックは、将来の画期的な進歩を展望しつつも、エビデンスに基づいたアプローチを強調しています。『Stem Cells』は、専門知識をより幅広い層に届けるというオックスフォードの使命を体現しており、科学界および教育界において信頼される入門書となっています。

幹細胞の基礎知識の要約をダウンロード

幹細胞の基礎知識の要約をPDFまたはEPUBで無料でダウンロード。印刷やオフラインでいつでもお読みいただけます。

他のユーザーのお気に入り

Andrew Steele

Siddhartha Mukherjee

Paul Klenerman

Robert M. Sapolsky

Simon Blackburn

Sharon Moalem

William E. Paul

James Hamblin

『幹細胞の基礎知識』の要約についてのよくある質問

この学習プランの一部

学習プラン

Learning about Nanobiotechnology

5 h 34 m•4 エピソード

学習プラン

Tissue engineering

5 h 9 m•4 エピソード

学習プラン

The Science of Self-Sabotage

This plan is essential for high-achievers and chronic caretakers who feel stuck in repetitive patterns of failure or burnout. It offers a deep dive into the neurobiology of behavior, making it ideal for anyone looking to reclaim control over their choices and mental well-being.

30 m•3 セクション

学習プラン

The Neuroscience of Manifestation

This plan bridges the gap between self-help and science, offering a biological perspective on achieving goals. It is ideal for high-performers and skeptics alike who want to leverage brain science to increase their personal agency and effectiveness.

1 h 30 m•3 セクション

学習プラン

The Smart Decade in Medicine

This learning plan explores the frontier where biology meets engineering, detailing the technologies redefining human health. It is essential for healthcare professionals, biotech investors, and tech enthusiasts looking to understand the next decade of medical innovation.

1 h 24 m•4 セクション

学習プラン

Becoming Supernatural: The Science of Self-Transformation

This learning plan bridges the gap between ancient wisdom and modern science for those seeking radical personal change. It is ideal for individuals looking to transcend their current limitations by mastering the intersection of neuroscience, biology, and mindfulness.

1 h 30 m•3 セクション

学習プラン

The Neurobiology of Unstoppable Growth

This plan is essential for leaders and high-performers who want to leverage brain science to overcome burnout and stagnation. It bridges the gap between biological reality and professional excellence, making it ideal for anyone navigating high-pressure environments.

1 h 30 m•3 セクション

学習プラン

From Anatomy to Athletics

This plan bridges the gap between historical medical science and the high-stakes world of sports medicine. It is ideal for aspiring healthcare professionals and athletes who want to understand the clinical logic behind physical performance and injury recovery.

1 h 30 m•3 セクション

学習プラン

Support and Science of Depression

This learning plan bridges the gap between clinical science and practical empathy, making it essential for anyone seeking to understand the mechanics of mental health. It is particularly beneficial for caregivers, students of psychology, or individuals looking for evidence-based insights into the recovery process.

2 h•4 セクション

学習プラン

The Biology of Moral Choice

This learning plan bridges the gap between neuroscience and ethics to reveal how our brains dictate our sense of right and wrong. It is essential for legal professionals, psychologists, and anyone interested in the biological roots of human behavior and accountability.

3 h•6 セクション

コロンビア大学卒業生が開発 | サンフランシスコ発

BeFreedは好奇心旺盛な仲間が集うグローバルコミュニティ

4.7

平均評価

7,840件以上のアプリ評価

BeFreedコミュニティ

正直、まだアプリを使いこなせていませんが、この数日使っただけで本当に感動しました… BeFreed は、今まで使ったどの学習アプリともレベルが違います。夢中になれるうえに集中力も実際に上がるので、スマホをだらだら見てしまう人にぴったりです！

@ladyInfinity

ちょうど 23 日前に BeFreed を購入して、それから毎日欠かさず使っています。仕事の流れと学習習慣に完全に溶け込みました。

@jayallen

正直なところ、このアプリは期待をすべて超えてきました。どんなテーマでも音声を生成してもらえて、その結果には驚かされます。私の専門は心理療法で、多分野にまたがる領域ですが、それでも回答はとても正確です。

@Raguipa

何よりありがたいのは、スマホをだらだら見る時間が減ったことです。探す時間が減って、吸収する時間が増えました。オーディオブック、ポッドキャスト、学習プランの組み合わせが素晴らしいです。

@colonyofcreatorsNGO

私は 24 年間、PhotoReading 加速学習のインストラクターをしています… 本と読書と学びが私の専門ですが、BeFreed は情報を消化しやすい形で届ける革新的なアプローチを見事に実現しています。

@BeFreed user

ただの本の要約アプリではありません。「ファン」スタイルを使ってみたら、従来のやり方よりずっと良い要約で、アイデアもつかみやすいです。これだけでも十分元が取れます。

@austinakon

このアプリが大好きです。数日使っただけで、聞くのが止まらなくなりました。始め方として最高です。

@jcrules328

本当に気に入っています。約 1 か月試していますが、まさに掘り出し物だと感じます。BeFreed で自分だけのテーマを作れるのが便利で、声も素晴らしく、ナレーションの選択肢は無限です。

@DanielCZ

正直、まだアプリを使いこなせていませんが、この数日使っただけで本当に感動しました… BeFreed は、今まで使ったどの学習アプリともレベルが違います。夢中になれるうえに集中力も実際に上がるので、スマホをだらだら見てしまう人にぴったりです！

@ladyInfinity

ちょうど 23 日前に BeFreed を購入して、それから毎日欠かさず使っています。仕事の流れと学習習慣に完全に溶け込みました。

@jayallen

正直なところ、このアプリは期待をすべて超えてきました。どんなテーマでも音声を生成してもらえて、その結果には驚かされます。私の専門は心理療法で、多分野にまたがる領域ですが、それでも回答はとても正確です。

@Raguipa

何よりありがたいのは、スマホをだらだら見る時間が減ったことです。探す時間が減って、吸収する時間が増えました。オーディオブック、ポッドキャスト、学習プランの組み合わせが素晴らしいです。

@colonyofcreatorsNGO

私は 24 年間、PhotoReading 加速学習のインストラクターをしています… 本と読書と学びが私の専門ですが、BeFreed は情報を消化しやすい形で届ける革新的なアプローチを見事に実現しています。

@BeFreed user

ただの本の要約アプリではありません。「ファン」スタイルを使ってみたら、従来のやり方よりずっと良い要約で、アイデアもつかみやすいです。これだけでも十分元が取れます。

@austinakon

このアプリが大好きです。数日使っただけで、聞くのが止まらなくなりました。始め方として最高です。

@jcrules328

本当に気に入っています。約 1 か月試していますが、まさに掘り出し物だと感じます。BeFreed で自分だけのテーマを作れるのが便利で、声も素晴らしく、ナレーションの選択肢は無限です。

@DanielCZ

役立つ情報やアイデアを 8〜15 分のポッドキャスト風音声にぎゅっとまとめて聞けるのが最高です。ポッドキャストは余計な話が多くて苦手でしたが、これは無駄を全部そぎ落としてくれます。

@BeFreed user

博士課程の仕上げの段階で、なじみのない資料を大量に読む必要があります… BeFreed ならプロンプトを入力するだけで、アプリが資料を探して音声ポッドキャストを作ってくれます。BeFreed のほうが NotebookLM よりも流れがスムーズだと感じます。

@Brad

朝食を作りながら、散歩しながら、通勤しながら聞くものを YouTube でよく探していましたが、BeFreed は広告も余計な話もなしで、もっと的を絞った聞き方をさせてくれます！

@BeFreed user

このプラットフォームの一番の魅力は、その万能さです。扱えないテーマは文字どおりひとつもありません。何を投げても応えてくれます… 制限がまったくないのに約束をきちんと果たしてくれる学習ツールには、なかなか出会えません。

@jayallen

BeFreed は素晴らしいです。使いやすいデザインのおかげで、操作に迷う時間が減り、学ぶ時間が増えました。オーディオブック、ポッドキャスト、学習プランの組み合わせは天才的で、毎日の習慣がすっかり変わりました。

@BeFreed user

最初はイタリア語でポッドキャストを作る方法を理解するのに少し時間がかかりましたが、わかった瞬間、最高でした！どんなテーマでも説明してもらえて、しかもとても賢く、うまく話してくれます！

@matteo77

BeFreed は毎日使うオーディオブックアプリになりました… 一番気に入っているのは、自分のテキストを入れると、外出先でも聞ける音声にしてくれるところです。

@kotanzu1

役立つ情報やアイデアを 8〜15 分のポッドキャスト風音声にぎゅっとまとめて聞けるのが最高です。ポッドキャストは余計な話が多くて苦手でしたが、これは無駄を全部そぎ落としてくれます。

@BeFreed user

博士課程の仕上げの段階で、なじみのない資料を大量に読む必要があります… BeFreed ならプロンプトを入力するだけで、アプリが資料を探して音声ポッドキャストを作ってくれます。BeFreed のほうが NotebookLM よりも流れがスムーズだと感じます。

@Brad

朝食を作りながら、散歩しながら、通勤しながら聞くものを YouTube でよく探していましたが、BeFreed は広告も余計な話もなしで、もっと的を絞った聞き方をさせてくれます！

@BeFreed user

このプラットフォームの一番の魅力は、その万能さです。扱えないテーマは文字どおりひとつもありません。何を投げても応えてくれます… 制限がまったくないのに約束をきちんと果たしてくれる学習ツールには、なかなか出会えません。

@jayallen

BeFreed は素晴らしいです。使いやすいデザインのおかげで、操作に迷う時間が減り、学ぶ時間が増えました。オーディオブック、ポッドキャスト、学習プランの組み合わせは天才的で、毎日の習慣がすっかり変わりました。

@BeFreed user

最初はイタリア語でポッドキャストを作る方法を理解するのに少し時間がかかりましたが、わかった瞬間、最高でした！どんなテーマでも説明してもらえて、しかもとても賢く、うまく話してくれます！

@matteo77

BeFreed は毎日使うオーディオブックアプリになりました… 一番気に入っているのは、自分のテキストを入れると、外出先でも聞ける音声にしてくれるところです。

@kotanzu1

BeFreedがウェブ上でどのように話題になっているかをもっと見る

今すぐ学習の旅を始めよう

第5章

『幹細胞の基礎知識』の要約

『幹細胞の基礎知識』の要約の概要

『幹細胞の基礎知識』の要約をさまざまな学習スタイルで探る

The Cellular Fountain of Youth: Unlocking the Power of Stem Cells

The Fundamental Nature of Stem Cells: Building Blocks of Life

聴きながら、すべての言葉を目で追えます

Embryonic Stem Cells: Potent but Controversial

Personalized Pluripotent Stem Cells: The Revolution of Reprogramming

『幹細胞の基礎知識』の要約をもっと深く楽しむ

Diabetes: The Prime Target for Stem Cell Therapy

Beyond Diabetes: The Wider Therapeutic Landscape

聴きながら、すべての言葉を目で追えます

The Hidden World of Tissue-Specific Stem Cells

Proven Therapies: Where Stem Cells Already Save Lives

『幹細胞の基礎知識』の要約をもっと深く楽しむ

Bridging Hope and Reality: The Future of Stem Cell Medicine

『幹細胞の基礎知識』の要約を最後まで読み終えました

『幹細胞の基礎知識』の要約の主要テーマ

『幹細胞の基礎知識』の要約の名言集

『幹細胞の基礎知識』の要約の登場人物

著者について

幹細胞の基礎知識の要約をダウンロード

他のユーザーのお気に入り

『幹細胞の基礎知識』の要約についてのよくある質問

What is Stem Cells: A Very Short Introduction about?

Who should read Stem Cells: A Very Short Introduction?

Is Stem Cells: A Very Short Introduction worth reading?

What are the main differences between embryonic and tissue-specific stem cells?

この学習プランの一部

Learning about Nanobiotechnology

Tissue engineering

もっと見る

BeFreedは好奇心旺盛な仲間が集うグローバルコミュニティ

『幹細胞の基礎知識』の要約をさまざまな学習スタイルで探る

The Cellular Fountain of Youth: Unlocking the Power of Stem Cells

The Fundamental Nature of Stem Cells: Building Blocks of Life

聴きながら、すべての言葉を目で追えます

Embryonic Stem Cells: Potent but Controversial

Personalized Pluripotent Stem Cells: The Revolution of Reprogramming

『幹細胞の基礎知識』の要約をもっと深く楽しむ

Diabetes: The Prime Target for Stem Cell Therapy

Beyond Diabetes: The Wider Therapeutic Landscape

聴きながら、すべての言葉を目で追えます

The Hidden World of Tissue-Specific Stem Cells

Proven Therapies: Where Stem Cells Already Save Lives

『幹細胞の基礎知識』の要約をもっと深く楽しむ

Bridging Hope and Reality: The Future of Stem Cell Medicine

『幹細胞の基礎知識』の要約を最後まで読み終えました

他のユーザーのお気に入り

この学習プランの一部

Learning about Nanobiotechnology

Tissue engineering

もっと見る